glp 1 trials Another milestone in the evolution of GLP-1-based diabetes therapies Novo Nordisk justifies reasoning behind
Description
Preclinical studies have identified GLP-1 receptors throughout the gastrointestinal tract, including on enteroendocrine cells, neurons, and immune cells
and is third-party tested
NICE guidance (NG69) advises against offering medication as the sole treatment for eating disorders
In fact, majority (70%) of insulin response after eating food is contributed to the incretins
Fiber is your best ally for preventing constipationa common side effect of GLP-1sbut it must be increased slowly
This is super critical for women in midlife
